Pall Introduces 13 mm Acrodisc® MS Syringe Filter Certified for Low LCMS Extractables in Small Samples

  Pall Introduces 13 mm Acrodisc® MS Syringe Filter Certified for Low LCMS
  Extractables in Small Samples

Business Wire

PORT WASHINGTON, N.Y. -- February 28, 2013

Pall Corporation (NYSE:PLL) has introduced a 13 mm Acrodisc^® MS syringe
filter certified for low extractables in high performance liquid
chromatography/mass spectrometry (LCMS) applications. The new 13 mm size,
which is designed specifically for small sample analysis using LCMS,
complements Pall’s current Acrodisc MS syringe filter offering of a 25 mm
filter. The 13 mm Acrodisc MS syringe filter improves the accuracy of testing,
enhances LCMS performance, and extends the longevity of testing

Pall's new 13 mm Acrodisc® MS syringe filter (Photo: Business Wire)

Pall's new 13 mm Acrodisc® MS syringe filter (Photo: Business Wire)

The low extractable levels of the new 13 mm Acrodisc MS syringe filter
minimize interference with the ionization process and reduce the need for
retesting. This lowers costs while minimizing downtime due to unexpected
contamination. To ensure high performance, product tubes are packaged
individually so that filters not in use remain sealed and protected from
external contamination.

Constructed with Pall’s new water wettable polytetrafluoroethylene (WWPTFE)
membrane in a unique high density polyethylene housing, the Acrodisc MS
syringe filter can be used with both organic and aqueous solvents. It offers
excellent chemical resistance and good particulate retention with minimal
protein adsorption. This protects instrument columns from particulate build-up
and reduces the frequency and cost of replacement. It also enables more
consistent LCMS testing performance.

“Pall’s 13 mm Acrodisc MS syringe filter is the newest innovation in our
comprehensive line of syringe filters and is suitable for samples as small as
25 µL,” said Larry O’Connell, senior vice president, Pall Laboratory Products.
“Our new size will continue to improve the accuracy, cost, and reliability of
high performance LCMS testing. The applications for this advancement are
extensive and growing rapidly as testing technology advances.”

To learn more about the Acrodisc MS syringe filter and other Pall Life
Sciences laboratory products, visit

Pall Life Sciences

Pall Life Sciences provides cutting-edge products and services to meet the
demanding needs of customers discovering, developing and producing biotech
drugs, vaccines and classic pharmaceuticals. The company’s membranes and
membrane devices optimize detection and sample preparation in the drug
research, clinical diagnostics, genomics, and proteomics markets. Pall is a
leading provider of separation systems and single-use filtration and
purification technologies to pharmaceutical and biotechnology companies to
support faster development of new drugs and vaccines that are safer and
require less energy and water to produce. Pall technologies are also used in
clinical institutions and the food and beverage industries.

About Pall Corporation

Pall Corporation (NYSE:PLL) is a filtration, separation and purification
leader providing solutions to meet the critical fluid management needs of
customers across the broad spectrum of life sciences and industry. Pall works
with customers to advance health, safety and environmentally responsible
technologies. The company’s engineered products enable process and product
innovation and minimize emissions and waste. Pall Corporation is an S&P 500
company serving customers worldwide. Pall has been named a “top green company”
by Newsweek magazine. To see how Pall is helping enable a greener, safer, more
sustainable future, follow us on Twitter @PallCorporation or visit

Note to Editors: A high-resolution photograph of the 13 mm Acrodisc MS syringe
filter is available for download at

Photos/Multimedia Gallery Available:



Pall Corporation
Laura Zaborski
Marketing Communications Manager
Telephone: 734-913-6488
Press spacebar to pause and continue. Press esc to stop.